BioPharma Drug Discovery
GeneQuantum Healthcare (Suzhou) Co., Ltd. (hereinafter referred to as "GeneQuantum"), a global innovative biotechnology company dedicated to the deve...
May 16, 2022 | News
The birth of a universal antiviral drug with a mechanism applicable to all viral infections is approaching. This antiviral agent, developed ...
May 13, 2022 | News
The 2022 CSCO Guidelines incorporate a total of four selinexor combination therapy regimens for relapsed myeloma. In addition, the guidelines also recommen...
May 13, 2022 | News
Swedish biopharmaceutical company TikoMed AB and IQVIA announce a key strategic collaboration with the aim to accelerate the development of TikoMed's lead ...
May 06, 2022 | News
The return to in-person meetings provides us with the opportunity to welcome you back to the BD booth -- which will show our wide range of services an...
May 04, 2022 | News
The Phase 3 trial will be conducted under the auspices of the first Regenerative Medicine Advanced Therapy (RMAT) designation approved by the FDA for an EV...
April 28, 2022 | News
LNK01004 is a novel kinase inhibitor that can simultaneously inhibit multiple inflammatory cytokines and block multiple signaling pathways related to psori...
April 25, 2022 | News
Terran to advance the development of two of Sanofi's Phase 3 CNS therapeutics Transaction includes worldwide exclusive rights for development and commer...
April 22, 2022 | News
The clearance was received several months after the successful first use of the Bendit21 neuro catheter in the USA in two life-saving procedures....
April 19, 2022 | News
This integration allows users to visualize and share plasmid information such as maps and sequences within the web-based CDD Vault application. Snap...
April 18, 2022 | News
Test detects 21 targets for 19 respiratory viruses in single tube, including COVID-19 and flu Assay result of Seegene's decades-long know-how, applies D...
April 07, 2022 | News
Hasten fast-tracks transformative medicines for patients in China Hasten Biopharmaceutic Co., Ltd (China) ("Hasten") today announced that it has ...
April 01, 2022 | News
Daewoong Pharmaceutical (CEO Sengho Jeon & Changjae Lee) recently announced that it has submitted the New Drug Application (NDA) for a n...
March 29, 2022 | News
DTX-021 is a botulinum toxin type A drug intended for the treatment of moderate to severe glabellar lines. DTX-021 is a highly purified and clinically test...
March 25, 2022 | News
Most Read
Bio Jobs
News
Editor Picks